High-Impact Form 4 Intelligence
Real-time SEC insider trading data with advanced filtering. Free beta.
Total Buys (Filtered)
$0
$0
Total Sells (Filtered)
$11.1M
$11,100,000
| Ticker | Company | Reporting Owner | Date | Value (USD) | Type | Form 4 |
|---|---|---|---|---|---|---|
|
MIRM
M
Mirum Pharmaceuticals, Inc.
GREY MICHAEL G
• Director
Equity Compensation
2025-12-19
$146,800x2
|
||||||
| MIRM |
Mirum Pharmaceuticals, Inc.
|
Director
Equity Compensation
|
2025-12-19 | $146,800x2 | M | Form 4 |
| MIRM |
Mirum Pharmaceuticals, Inc.
|
Director
10b5-1 Sell
|
2025-12-19 | $3,900,000Large | S | Form 4 |
|
MIRM
M
Mirum Pharmaceuticals, Inc.
GREY MICHAEL G
• Director
Equity Compensation
2025-12-01
$146,800x2
|
||||||
| MIRM |
Mirum Pharmaceuticals, Inc.
|
Director
Equity Compensation
|
2025-12-01 | $146,800x2 | M | Form 4 |
| MIRM |
Mirum Pharmaceuticals, Inc.
|
Director
10b5-1 Sell
|
2025-12-01 | $3,700,000Large | S | Form 4 |
| MIRM |
Mirum Pharmaceuticals, Inc.
|
Director
Other
|
2025-11-21 | $146,800 | M | Form 4 |
| MIRM |
Mirum Pharmaceuticals, Inc.
|
Director
10b5-1 Sell
|
2025-11-21 | $3,500,000Large | S | Form 4 |